Role of glutathione in prevention of acetaminophen-induced hepatotoxicity by N-acetyl-L-cysteine in vivo: studies with N-acetyl-D- cysteine in mice

GB Corcoran and BK Wong

The revelation that many covalent binding estimates are falsely low due to flawed normalization discloses that protection by N-acetyl-L- cysteine against acetaminophen hepatotoxicity is accompanied routinely by a 50 to 80% decline in arylation. Elevated glutathione may be responsible for inhibiting covalent binding but above-normal concentrations have never been demonstrated in vivo after N-acetyl-L- cysteine treatment or separated adequately from other possible hepatoprotective actions including direct reduction of the toxic acetaminophen metabolite by the antidote. This led us to compare the conventional L-isomer of the antidote to its nonphysiologic stereoisomer, N-acetyl-D-cysteine, because the latter should be capable of reducing the toxic metabolite but not of stimulating glutathione biosynthesis. Oral coadministration of N-acetyl-D-cysteine (1200 mg/kg), however, failed in preventing the elevation of serum alanine aminotransferase activity, in decreasing hepatocellular necrosis, in interdicting covalent binding of the toxic metabolite to hepatocellular proteins and in preventing the depletion of liver glutathione caused by 500 mg/kg of acetaminophen. N-acetyl-L-cysteine succeeded in decreasing these measures of acetaminophen hepatotoxicity while driving liver glutathione concentrations 2-3 fold above control values. The L-isomer also increased urinary excretion of glutathione-derived acetaminophen metabolites whereas the D-isomer increased only acetaminophen sulfate excretion and reversed the customary predominance of acetaminophen cysteine over the mercapturic acid conjugate. Liver uptake of N-acetyl- D-cysteine was reflected in organ concentrations 7-fold higher than noted for the L-isomer.(ABSTRACT TRUNCATED AT 250 WORDS)

Volume 238, Issue 1, pp. 54-61, 07/01/1986
Copyright © 1986 by American Society for Pharmacology and Experimental Therapeutics

This article has been cited by other articles:

				S. Fishbane N-Acetylcysteine in the Prevention of Contrast-Induced Nephropathy Clin. J. Am. Soc. Nephrol., January 1, 2008; 3(1): 281 - 287. [Abstract] [Full Text] [PDF]

				L. A. McConnachie, I. Mohar, F. N. Hudson, C. B. Ware, W. C. Ladiges, C. Fernandez, S. Chatterton-Kirchmeier, C. C. White, R. H. Pierce, and T. J. Kavanagh Glutamate Cysteine Ligase Modifier Subunit Deficiency and Gender as Determinants of Acetaminophen-Induced Hepatotoxicity in Mice Toxicol. Sci., October 1, 2007; 99(2): 628 - 636. [Abstract] [Full Text] [PDF]

				M. V. Terneus, K. K. Kiningham, A. B. Carpenter, S. B. Sullivan, and M. A. Valentovic Comparison of S-Adenosyl-L-methionine and N-Acetylcysteine Protective Effects on Acetaminophen Hepatic Toxicity J. Pharmacol. Exp. Ther., January 1, 2007; 320(1): 99 - 107. [Abstract] [Full Text] [PDF]

				S. Fishbane, J. H. Durham, K. Marzo, and M. Rudnick N-Acetylcysteine In The Prevention Of Radiocontrast-Induced Nephropathy J. Am. Soc. Nephrol., February 1, 2004; 15(2): 251 - 260. [Abstract] [Full Text] [PDF]

				L. P. James, S. S. McCullough, L. W. Lamps, and J. A. Hinson Effect of N-Acetylcysteine on Acetaminophen Toxicity in Mice: Relationship to Reactive Nitrogen and Cytokine Formation Toxicol. Sci., October 1, 2003; 75(2): 458 - 467. [Abstract] [Full Text] [PDF]

				K. Shankar, V. S. Vaidya, U. M. Apte, J. E. Manautou, M. J. J. Ronis, T. J. Bucci, and H. M. Mehendale Type 1 Diabetic Mice Are Protected from Acetaminophen Hepatotoxicity Toxicol. Sci., June 1, 2003; 73(2): 220 - 234. [Abstract] [Full Text] [PDF]

				F. A. Nicholls-Grzemski, I. C. Calder, B. G. Priestly, and P. C. Burcham Clofibrate-Induced in Vitro Hepatoprotection against Acetaminophen Is Not Due to Altered Glutathione Homeostasis Toxicol. Sci., July 1, 2000; 56(1): 220 - 228. [Abstract] [Full Text] [PDF]

				A. H. Boulares, C. Giardina, M. S. Inan, E. A. Khairallah, and S. D. Cohen Acetaminophen Inhibits NF-{kappa}B Activation by Interfering with the Oxidant Signal in Murine Hepa 1-6 Cells Toxicol. Sci., June 1, 2000; 55(2): 370 - 375. [Abstract] [Full Text] [PDF]

				P J O'Brien, M R Slaughter, A Swain, J M Birmingham, R W Greenhill, F Elcock, and P J Bugelski Repeated acetaminophen dosing in rats: adaptation of hepatic antioxidant system Human and Experimental Toxicology, May 1, 2000; 19(5): 277 - 283. [Abstract] [PDF]

				W. F. Salminen Jr., R. Voellmy, and S. M. Roberts Effect of N-Acetylcysteine on Heat Shock Protein Induction by Acetaminophen in Mouse Liver J. Pharmacol. Exp. Ther., July 1, 1998; 286(1): 519 - 524. [Abstract] [Full Text]